MRC & Asthma UK Centre in Allergic Mechanisms of Asthma

Contact Details

Clinical Studies Unit

Royal Brompton Hospital

First Floor, Fulham Road

London

SW36HP

Telephone

020 7351 8974

Email

t.hansel@imperial.ac.uk

Profile

Since July 2009 Trevor Hansel has been Medical Director of the Imperial Clinical Respiratory Research Unit (ICRRU) located at St. Mary’s Hospital within Imperial College. In addition, he is an Honorary Consultant and Reader in Respiratory Clinical Pharmacology. He obtained his medical degree in 1982 at the Welsh National School of Medicine, Cardiff and then completed higher specialist medical training in clinical immunology in Birmingham. From 1990-1993 Trevor then carried out a PhD on eosinophil in asthma in Davos, Switzerland. Following this he worked in respiratory drug development with Sandoz and Roche in Basel. In addition, he has regulatory experience from the Biotechnology Unit of the Medicines Control Agency (MCA) in London. Trevor has a specialist interest in phase II clinical testing of new anti-inflammatory therapies for asthma and COPD. Novel methods have been developed for nasal allergen challenge, coupled with use of serial Synthetic Absorptive Matrices (SAM) to measure cytokines and chemokines in nasal lining fluid. Trevor Hansel and Peter Barnes are authors of “An Atlas of COPD” (Parthenon, 2004). Hansel and Barnes are currently editing Thomson Reuters: New Drugs and Targets for Asthma and COPD, that will be published in 2010.

MRC & Asthma UK Centre in Allergic Mechanisms of Asthma

Last modified: 04 December 2009 11:38